Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Changes in peripheral blood lymphocytes in polycythemia vera and essential thrombocythemia patients treated with pegylated-interferon alpha and correlation with JAK2V617F allelic burden.

Kovacsovics-Bankowski M, Kelley TW, Efimova O, Kim SJ, Wilson A, Swierczek S, Prchal J.

Exp Hematol Oncol. 2016 Sep 27;5:28. eCollection 2015.

2.

CD229 is expressed on the surface of plasma cells carrying an aberrant phenotype and chemotherapy-resistant precursor cells in multiple myeloma.

Yousef S, Kovacsovics-Bankowski M, Salama ME, Bhardwaj N, Steinbach M, Langemo A, Kovacsovics T, Marvin J, Binder M, Panse J, Kröger N, Luetkens T, Atanackovic D.

Hum Vaccin Immunother. 2015;11(7):1606-11. doi: 10.1080/21645515.2015.1046658.

3.

Detailed characterization of tumor infiltrating lymphocytes in two distinct human solid malignancies show phenotypic similarities.

Kovacsovics-Bankowski M, Chisholm L, Vercellini J, Tucker CG, Montler R, Haley D, Newell P, Ma J, Tseng P, Wolf R, Vetto JT, Hammill C, Hansen P, Weinberg AD.

J Immunother Cancer. 2014 Nov 18;2(1):38. doi: 10.1186/s40425-014-0038-9. eCollection 2014.

4.

OX40 is a potent immune-stimulating target in late-stage cancer patients.

Curti BD, Kovacsovics-Bankowski M, Morris N, Walker E, Chisholm L, Floyd K, Walker J, Gonzalez I, Meeuwsen T, Fox BA, Moudgil T, Miller W, Haley D, Coffey T, Fisher B, Delanty-Miller L, Rymarchyk N, Kelly T, Crocenzi T, Bernstein E, Sanborn R, Urba WJ, Weinberg AD.

Cancer Res. 2013 Dec 15;73(24):7189-7198. doi: 10.1158/0008-5472.CAN-12-4174. Epub 2013 Oct 31.

5.

The TNFRs OX40, 4-1BB, and CD40 as targets for cancer immunotherapy.

Moran AE, Kovacsovics-Bankowski M, Weinberg AD.

Curr Opin Immunol. 2013 Apr;25(2):230-7. doi: 10.1016/j.coi.2013.01.004. Epub 2013 Feb 14. Review.

6.

Science gone translational: the OX40 agonist story.

Weinberg AD, Morris NP, Kovacsovics-Bankowski M, Urba WJ, Curti BD.

Immunol Rev. 2011 Nov;244(1):218-31. doi: 10.1111/j.1600-065X.2011.01069.x. Review.

7.

Signaling through OX40 enhances antitumor immunity.

Jensen SM, Maston LD, Gough MJ, Ruby CE, Redmond WL, Crittenden M, Li Y, Puri S, Poehlein CH, Morris N, Kovacsovics-Bankowski M, Moudgil T, Twitty C, Walker EB, Hu HM, Urba WJ, Weinberg AD, Curti B, Fox BA.

Semin Oncol. 2010 Oct;37(5):524-32. doi: 10.1053/j.seminoncol.2010.09.013. Review.

8.

Clinical scale expanded adult pluripotent stem cells prevent graft-versus-host disease.

Kovacsovics-Bankowski M, Streeter PR, Mauch KA, Frey MR, Raber A, van't Hof W, Deans R, Maziarz RT.

Cell Immunol. 2009;255(1-2):55-60. doi: 10.1016/j.cellimm.2008.10.004. Epub 2008 Nov 20.

PMID:
19022422
9.

Pre-clinical safety testing supporting clinical use of allogeneic multipotent adult progenitor cells.

Kovacsovics-Bankowski M, Mauch K, Raber A, Streeter PR, Deans RJ, Maziarz RT, Van't Hof W.

Cytotherapy. 2008;10(7):730-42. doi: 10.1080/14653240802320245.

PMID:
18985479
10.

Two adjacent trimeric Fas ligands are required for Fas signaling and formation of a death-inducing signaling complex.

Holler N, Tardivel A, Kovacsovics-Bankowski M, Hertig S, Gaide O, Martinon F, Tinel A, Deperthes D, Calderara S, Schulthess T, Engel J, Schneider P, Tschopp J.

Mol Cell Biol. 2003 Feb;23(4):1428-40.

11.

Secondary amyloidosis: a severe complication of ankylosing spondylitis. Two case-reports.

Kovacsovics-Bankowski M, Zufferey P, So AK, Gerster JC.

Joint Bone Spine. 2000;67(2):129-33.

PMID:
10769106
12.

[Thromboangiitis obliterans (Buerger disease) discovered by symptoms of arthralgia in a young woman].

Kovacsovics-Bankowski M, Gerster JC.

Praxis (Bern 1994). 1997 Dec 3;86(49):1945-8. French.

PMID:
9480517
13.

Analysis of MHC class II presentation of particulate antigens of B lymphocytes.

Vidard L, Kovacsovics-Bankowski M, Kraeft SK, Chen LB, Benacerraf B, Rock KL.

J Immunol. 1996 Apr 15;156(8):2809-18.

PMID:
8609400
14.

Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity.

Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL.

Nat Med. 1995 Jul;1(7):649-53.

PMID:
7585145
15.

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules.

Kovacsovics-Bankowski M, Rock KL.

Science. 1995 Jan 13;267(5195):243-6.

PMID:
7809629
17.

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.

Kovacsovics-Bankowski M, Clark K, Benacerraf B, Rock KL.

Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):4942-6.

18.

Isotypic distribution of HIV-1-specific antibodies in individuals from central Africa.

Kovacsovics-Bankowski M, Carini C, Kashala O, Essex M.

Viral Immunol. 1992 Winter;5(4):243-8.

PMID:
1472277

Supplemental Content

Loading ...
Support Center